U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07546357) titled 'AIManage Using an AI-driven CDS and Chatbot' on April 10.
Brief Summary: The objective of this project is to define and test the GenAI-powered Clinical Decision Support (CDS) tool, AIManage, providing a broad range of incretin mimetic medication management services to optimize dose titrations. The study will take place across primary care and obesity medicine clinics at NYUH.
The study is currently conducting formative data collection for tool refinement (Phase 1). Once completed, a cluster randomized controlled trial of the AIManage tool will be undertaken (Phase 2).
Study Start Date: June 01
Study Type: INTERVENTIONAL
Conditi...